Histamine H3 Receptor Antagonist Enhances Neurogenesis and Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairments
Chronic cerebral hypoperfusion (CCH) is a neurodegenerative disease, which induces cognitive impairments in the central nervous system (CNS). Histamine H3 receptor (H3R) is an autoreceptor involved in the modulation of neurogenesis and synaptic plasticity in the CNS. However, the role of H3R in CCH-...
Main Authors: | Na Wang, Jing Ma, Jing Liu, Jiangong Wang, Cuilan Liu, Hua Wang, Yong Liu, Haijing Yan, Shujun Jiang |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Frontiers Media S.A.
2020-01-01
|
סדרה: | Frontiers in Pharmacology |
נושאים: | |
גישה מקוונת: | https://www.frontiersin.org/article/10.3389/fphar.2019.01583/full |
פריטים דומים
-
FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway
מאת: Miao Zhang, et al.
יצא לאור: (2021-01-01) -
Enhancement of the anticonvulsant effect of the h3 histamine receptor blocker thioperamid against the use of pioglitazone
מאת: O. Yehorenko, et al.
יצא לאור: (2022-04-01) -
Cortex-specific transcriptome profiling reveals upregulation of interferon-regulated genes after deeper cerebral hypoperfusion in mice
מאת: Zengyu Zhang, et al.
יצא לאור: (2023-03-01) -
The involvement of central nervous system histamine receptors in psychological stress-induced exacerbation of allergic airway inflammation in mice
מאת: Tomomitsu Miyasaka, et al.
יצא לאור: (2016-09-01) -
Baseline Characteristics Associated with Good Collateral Status Using Hypoperfusion Index as an Outcome
מאת: Omar Hamam, et al.
יצא לאור: (2022-07-01)